Navigation Links
Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
Date:8/28/2013

ts; government and commercial reimbursement and pricing decisions; risks related to relying on collaborative arrangements; the timing and receipt of payments and fees, if any, from collaborators; the entry into or modification or termination of collaborative arrangements; unexpected or unfavorable new data; nonclinical and clinical data is voluminous and detailed, and regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; data and other information related to any of Arena's research and development may not meet regulatory requirements or otherwise be sufficient for further research and development, regulatory review or approval or continued marketing; Arena's ability to obtain and defend patents; the timing, success and cost of Arena's research and development; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; having adequate funds; and satisfactory resolution of litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersCindy McGee, Vice President,

David Schull, PresidentInvestor Relations & Alliance Management


'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
2. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
3. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
4. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
5. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
6. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
7. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
8. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
9. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
10. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
11. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rd24gk/chromatography ... "Chromatography (Instruments and Reagents) Global Market - Forecast ... Chromatography is an analytical technique, a method ... complex mixture by differential movement through a two ... considered chromatography as an esoteric art, which mainly ...
(Date:5/6/2015)... 6, 2015   CEFALY Technology , the creators ... specifically authorized for use prior to the onset of ... migraine treatment at the EUROHEADPAIN - Midterm Meeting at ... Spain , from May 14-17, 2015. ... EUROHEADPAIN, a major European research project focused on migraines, ...
(Date:5/6/2015)... Advanced wound care - assess products, developments, and revenue ... for the advanced wound care market? ... to 2025, assessing data, trends, opportunities and prospects there. ... tables, charts, and graphs covering 12 distinct submarket segments. ... the future market prospects. You will see financial results, ...
Breaking Medicine Technology:Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
... technologyOCEANSIDE, N.Y., May 18 Ellman International, Inc. ... (FDA) has granted clearance to Pelleve(TM), a skin ... to moderate facial wrinkles and rhytids for skin ... clinical data demonstrating that a single treatment with ...
... Biopure Corporation (Nasdaq: BPUR ) ... has advised the U.S. Naval Medical Research Center (NMRC) by ... Biopure,s oxygen therapeutic Hemopure(R) [hemoglobin glutamer -- 250 (bovine)] under ... As previously announced, the study, "Restore Effective Survival in ...
Cached Medicine Technology:Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles 2Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles 3U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 2U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 3
(Date:5/6/2015)... 2015 Baptist Medical Center Jacksonville ... in north Florida and southeast Georgia region offering ... innovation in total hip replacement surgery performed using ... arm that enables the accurate alignment and positioning ... offered MAKOplasty® partial knee resurfacing using the RIO ...
(Date:5/6/2015)... 06, 2015 “ SideChef ” was featured on ... at the latest and coolest applications on the market for iOS, ... expert, conducted the app review and shared with viewers how this ... day when to be a good navigator people had to know ... now everyone is a master navigator. Well what if people could ...
(Date:5/6/2015)... Anitha Nallari, MD has joined ... Inc. in Columbus, OH. Dr. Nallari will see patients ... in breast cancer, lung cancer, GI and gallbladder cancer, head ... benign hematology. , Dr. Anitha Nallari is Board ... American Board of Internal Medicine. She completed her medical education ...
(Date:5/6/2015)... Follow us on LinkedIn ... by the rising consumer awareness over the importance of ... Hand washing is becoming a part of personal hygiene ... infections. Periodic outbreak of Avian flu, Swine flu, and ... disease (EVD) epidemic in West Africa are mega ...
(Date:5/6/2015)... has opened press registration for TU-Automotive Detroit as the ... headlines of major publications world-wide. With 150+ speakers from ... to share their visions for the future of connected ... to go behind the scenes and hear major automakers’ ... year we’re releasing a preview of all the major ...
Breaking Medicine News(10 mins):Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:Press Registration for TU-Automotive Detroit Now Open 2
... a major advance in the treatment of prostate cancer, scientists ... tea inhibit cancer growth. This new discovery, published online in ... antioxidants in red wine and green tea produce a combined ... prostate cancer growth. This finding is important because it may ...
... PHOENIX, Ariz. June 9, 2010 Joshua Niska, a ... a string of major academic honors today by being named ... TODAY. Niska and other members of the national newspaper,s ... $2,500 cash award. They were selected, according to the newspaper, ...
... may make a new, experimental anti-cancer drug effective against a ... at Chicago College of Medicine have found. A man-made ... to cause tumor cells to die while leaving normal cells ... one of the chemical building blocks of DNA. Andrei Gartel, ...
... assisted reproduction (MAR) have fiscal implications for government both ... Based on public funding to conceive a MAR child ... costs, and future tax contributions of this child - ... government spending and tax revenue) of a child born ...
... are associated with increased teenage car crash rates, according to ... 2010, in San Antonio, Texas, at SLEEP 2010, the 24th ... Results indicate that in 2008 the teen crash rate was ... school classes began at 7:20 a.m., than in adjacent Chesapeake, ...
... blood vessel-blocking drug called tasquinimod slowed the rate of ... cancer patients, according to experts at Johns Hopkins, Roswell ... a so-called "anti-angiogenesis" drug that squeezes off blood supply ... Tumors require these vast networks of blood vessels ...
Cached Medicine News:Health News:Polyphenols in red wine and green tea halt prostate cancer growth 2Health News:TGen intern named one of nation's top 20 students by USA Today 2Health News:TGen intern named one of nation's top 20 students by USA Today 3Health News:Compound enhances cancer-killing properties of agent in trials 2Health News:Is IVF good value for money? Why funding of assisted reproduction is sound fiscal policy 2Health News:Is IVF good value for money? Why funding of assisted reproduction is sound fiscal policy 3Health News:Teen automobile crash rates are higher when school starts earlier 2Health News:Drug that restricts blood supply to prostate tumors delays disease progression 2
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
Designated most popular model or size. 3 mm tip....
Designated most popular model or size. Slightly angled, 2 mm wide....
Medicine Products: